Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Spoonful of technology: April-June 2025
Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.
Read more
Spoonful of technology: April-June 2025
Explore the latest technology that is changing the pharma industry, and discover how these innovations could solve key health challenges.
Spotlight: June 2025
From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round up.
AstraZeneca ranks top in science graduates' survey
Rising one place to number one overall, the British drugmaker has overtaken the NHS as the preferred destination for these graduates.
Bayer’s Stefan Oelrich elected as new EFPIA President
Stefan Oelrich has been newly elected President of the EFPIA, as new leadership calls for action to restore Europe’s global leadership in pharma innovation.
FDA removes hurdle to CAR T-cell therapies
The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.
Sun Pharma appoints Richard Ascroft as North American CEO
Ascroft brings more than 30 years of industry experience, including senior roles at Takeda Pharmaceuticals.
US withdraws funding from Gavi, the Vaccine Alliance
The US plans to stop its financial contributions to Gavi, the Vaccine Alliance, marking an end to an over 20-year partnership.
New survey takes patient pulse on AI in healthcare
The survey found that, while 57% of patients support the use of AI in the examination room, they are less enthusiastic about diagnostics.
Loading posts...
1
2
3
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View